Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
X4 Pharmaceuticals Announces EMA Validation of Marketing Authorization Application (MAA) for Mavorixafor - licenced to Norgine for commercialisation in Europe. 2025-01-25 02:00
Kelun-Biotech's Product Tagitanlimab Approved for Marketing in Second Indication in Combination with Cisplatin and Gemcitabine For the First-line Treatment of Patients with recurrent or metastatic NPC 2025-01-23 13:44
GC Cell Symposium with Bifarma Expands Global Impact and Reach for Immuncell-LC 2025-01-23 09:30
Pictor Biotech Inc. (d.b.a. SOLARBIOTECH), GPC Bio, and Eleszto Genetika Announce Strategic Unification 2025-01-23 05:53
2025 Japan Prize Laureates Announced 2025-01-22 15:00
Lepu Biopharma has granted ArriVent Exclusive License for MRG007, a Potential Best-in-Class ADC for the treatment of Gastrointestinal Cancers 2025-01-22 12:19
The BioCircular Materials Alliance initiated by Spiber welcomes new partners including Stella McCartney and publishes its first Progress Report 2025-01-21 18:00
SIRPAD - WORLD'S LARGEST RCT INVESTIGATING MAGICTOUCH PTA SIROLIMUS COATED BALLOON COMPLETES PATIENT ENROLMENT 2025-01-20 21:44
Boosting Yeast Protein Production to Meet the Growing Global Demand for Alternative Proteins 2025-01-17 22:46
Innovent and ASK Pharm Jointly Announce NMPA Approval of Limertinib, a Third-generation EGFR TKI for the Treatment of Lung Cancer 2025-01-17 08:00
Innovent Presents at the 43rd Annual J.P. Morgan Healthcare Conference 2025-01-17 07:00
Concept Medical Announces First Patient Enrollment in the MAGICAL BTK IDE Trial, Launching its PAD Clinical Program in the United States 2025-01-17 03:15
BGI Genomics Empowers Brunei's National Cervical Cancer Prevention Program 2025-01-16 12:51
Innovent Receives NMPA Breakthrough Therapy Designation for IBI343 (Anti-CLDN18.2 ADC) as Monotherapy for Advanced Pancreatic Cancer 2025-01-16 08:03
Samsung Biologics presents business updates at 2025 J.P. Morgan Healthcare Conference 2025-01-15 09:40
Axcynsis Therapeutics Receives FDA Clearance for IND Application of AT03-65, a Differentiated CLDN6-Targeting ADC, Powered by AxcynDOT™ Technology 2025-01-15 09:00
Stämm's Continuous Bioreactor Increases Antibody Productivity by up to 30x in European and American Pilots 2025-01-15 03:56
Endogenex™ Appoints Krissy Wright as Chief Financial Officer 2025-01-14 21:32
Telix Presentation to the 43rd Annual J.P. Morgan Healthcare Conference 2025-01-14 05:43
BioCina and NovaCina Merger Bolsters Global CDMO Industry 2025-01-14 00:43
1 2 3 4 5 235